Factors Influencing Prescribing of Statins in Singapore Compared to Queensland, Australia
Access Status
Authors
Date
2016Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Collection
Abstract
HMG-CoA reductase inhibitors (statins) are widely prescribed for dyslipidaemia with established benefits in reducing cardiovascular disease mortality and morbidity. Controversy remains surrounding statin use in low risk patients and patients of certain ethnicities. The aim of this study was to identify factors which influence the prescribing of statins by interviewing doctors from Queensland, Australia and Singapore. Purposive interviews were conducted with prescribers in Queensland Australia (n=20) and Singapore (n=21) to determine factors influencing statin prescribing. Cost, availability of generics and statin potency were major factors significantly influencing Singaporean prescribers compared to Australian prescribers (p<0.05). Although not significant, the potential for drug interactions also impacted statin prescribing in Singapore compared to Australia (p=0.0516). Cost and statin potency were major factors influencing the prescribing of statins in Singapore compared to Australia. Patients may be prescribed the cheaper, less potent statins potentially resulting in reduced patient benefits.
Related items
Showing items related by title, author, creator and subject.
-
Kurniawan, Dede Indra (2007)Background. Muscle cramps are one of the adverse affects suffered by hypercholesterolemia patients who are treated with statins. Besides reducing cholesterol levels, statins also reduce coenzyme Q10 (CoQ10) blood levels. ...
-
Ko, H.; Lareu, Ricky R.; Dix, B.; Hughes, J. (2017)© 2017 Ko et al. Introduction. The repurposing of non-antibiotic drugs as adjuvant antibiotics may help break antimicrobial resistance (AMR). Statins are commonly prescribed worldwide to lower cholesterol. They also possess ...
-
Schmid, O.; Stafford, Leanne; Bereznicki, L. (2015)© 2015 John Wiley & Sons Ltd.Summary What is known and objective Ischaemic heart disease (IHD) is a major cause of death in developed countries. Patients with IHD are at greater risk of subsequent myocardial infarction ...